About the list.
This is a work in progress. KEI has been engaged in the negotiations for a WIPO treaty on copyright exceptions for persons with disabilities since 2008. We have attended each negotiation that has been open to accredited NGOs, and participated in countless briefing and meetings with negotiators and key players in the negotiation.
Professor Brook Baker has written a 5800 word commentary on the negotiations for a treaty on copyright exceptions for persons who blind or have other disabilities. A copy of the paper is available here. The title of the paper is:
Challenges Facing a Proposed WIPO Treaty for Persons Who are Blind or Print Disabled
Professor Brook K. Baker
Law and Society Association Annual Meeting, June 2, 2013
Business Europe seeks to block WIPO treaty on copyright exceptions for persons who are blind or have other disabilitiesSubmitted by James Love on 17. May 2013 - 6:38
|Markus Beyrer thinks blind people should not have robust copyright exceptions, because it might set a precedent for patents on health or climate technologies|
Joint Letter to the 66th World Health Assembly: Follow-up of the report of the CEWG
20 May 2013
We urge the World Health Organization (WHO) and its Member States to exercise leadership, ambition and innovative thinking in developing new paradigms to take forward the work of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) in reconciling the objectives of stimulating medical innovation and ensuring access for all.
Supreme Court Unanimously Finds Patent Exhaustion Does Not Apply to Seeds; Leaves Door Open on Other Self-Replicating TechnologySubmitted by Krista Cox on 16. May 2013 - 11:01
On Monday, 13 May 2013, the Supreme Court of the United States unanimously held that patent exhaustion does not apply to second, third or nth generations of seeds. In an opinion authored by Justice Kagan, the court found that patent exhaustion does not apply to seeds because later generations constitute new copies of the invention.
UK IPO office releases emails that show close collaboration with publishers on WIPO treaty for the blindSubmitted by James Love on 11. May 2013 - 16:16
On May 10, 2013, a very revealing freedom of information request was made available from the UK Intellectual Property Office (IPO). The request had been filed on April 14, 2013 by the journalist Glyn Moody, for:
A PDF version of our comments is available here.
People have until midnight May 10, 2013 to file comments, here:
This is the table of contents.
Comments on the Administration’s Intention to Enter Into Negotiations for the Transatlantic Trade and Investment Partnership (TTIP) Agreement
Response to Docket No. USTR-2013-0019
Note, we are adding some video clips from the meeting here:
On May 13, 2013, KEI will host a 12:30 to 2:30 brown bag lunch for a discussion of the WIPO Treaty for the Blind negotiations. It will be possible to attend in person, or follow the meeting on the telephone.
Intellectual Property Owners Association (IPO) calls WIPO treaty for blind "dangerous precedent for other areas of IP Law"Submitted by James Love on 6. May 2013 - 13:17
On April 15, 2013, the Intellectual Property Owners Association (IPO) sent a letter to Teresa Stanek Rea, the Acting Under Secretary of Commerce for Intellectual Property and the Director of the U.S. Patent and Trademark Office, setting out the IPO "concerns" about the proposed WIPO treaty for persons who are blind or visually impaired. (Copy here).
On April 26, 2013 I attended a half day meeting on "A Human Rights Approach to Intellectual Property and Access to Medicines" organized by the Yale Law School and the Yale School of Public Health. These are notes from my interventions on behalf of KEI.
1. KEI does a lot of work on intellectual property rights that has impact on human rights. We do not always give prominence to human rights law or the language of human rights, although at times and in the right context, it can be important to do so.
Key points in the PhRMA release:
* PhRMA "dismayed that USTR did not grant an out-of-cycle review for India." PhRMA claims that India decisions involving German owned Bayer and Swiss owned Novartis "disproportionately impacted U.S. biopharmaceutical companies." (Perhaps PhRMA could have said, companies that have ownership claims on the US government).
Today USTR held a one hour "listening session" with several Washington, DC public interest groups. The topic was the Transatlantic Trade and Investment Partnership (TTIP) with the European Union.
On 1 May 2013, USTR released its 2013 Special 301 Report. Ukraine was put on the Priority Foreign Country list this year, a designation not used by USTR for several years. USTR's 2013 report spends more than six pages discussing China and two full pages on India. Below are some comments regarding this year's report.
Least Developed Countries
On 18 December 2012 and 20 December 2012, the World Trade Organization (WTO) undertook a trade policy review of the United States of America. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The questions raised by WTO Members during the US TPR touched upon on compulsory licensing (including cases of judicial compulsory licensing following eBay v. MercExchange), copyright (Golan v. Holder), the Special 301 report and the Medicines Patent Pool. On 30 April 2013, the WTO released the records of the meeting including WT/TPR/M/275.
Below are several links to recent Huffington Post articles about the WIPO negotiations for a treaty on copyright exceptions for blind persons.
The first is a link to my report for HuffPo on the April 2013 negotiations, which have not gone well. The blog includes a discussion of some of the changes in key provisions of the text over time, and the recent quite harmful MPAA lobbying efforts.